How to treat lung cancer caused by melanoma

Of the many different types of cancer that exist, asbestos-caused lung melanoma, also known as bronchial carcinoma and mesothelioma, is now responsible for 1% of all cancer-related deaths worldwide. Mesothelioma cancer is directly associated with asbestos exposure, which shows no immediate harmful signs to health and takes many years to develop within the body. Although it is extremely difficult to treat, once diagnosed, Chemotherapy, Immunotherapy and Stereotactic Body Radiosurgery have been used with some success.

Chemotherapy It is commonly used to treat mesothelioma cancer due to its ability to directly attack or poison dividing cancer cells anywhere in the body. However, healthy cells are also affected during the treatment, causing side effects that are generally attributed to patients’ hair loss, as hair cells are attacked along with normal bone marrow and gastrointestinal cells. Dacarbazine and temozolomide are two chemotherapeutic drugs that are frequently used in cancers with disseminated melanoma, of which up to 20% of all patients who have been treated with either drug have experienced marked reduction in the size of the cells. their tumors.

immunotherapy is another option, as it works by increasing the capacity of the immune system, which in turn enables the immune system to fight cancer cells. The side effects are less severe than those of chemotherapy, however, patients often experience severe flu-like symptoms that last for the duration of treatment. Interferon alpha and interleukin-2 are two drugs often used to treat spreading melanoma cancers, both of which, when given to patients in high doses, help boost the immune system.

Body Stereotactic Radiosurgery it is also used to treat mesothelioma cancer. The patient is first immobilized in a frame to stop any movement, as computer imaging techniques are then used to pinpoint precisely where the cancer cells are. These cells, in turn, are destroyed by receiving high doses of radiation. The treatment is particularly effective against mesothelioma cancer because it allows high doses of radiation to be precisely delivered, which kill cancer cells while causing minimal damage to surrounding healthy cells. Although, this treatment is only recommended for use in relatively healthy patients.

Surgery it’s a latter outcome, and it’s something that’s generally not recommended with disseminated melanoma lung cancers. The prognosis is often poor, as the five to ten year survival rate of patients is generally estimated to be less than 25%.